The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis.

Trial Profile

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 21 May 2013

At a glance

  • Drugs Montelukast (Primary) ; Fluticasone propionate
  • Indications Perennial allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2010 QOL results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology
    • 01 Apr 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Planned end date changed from 1 Dec 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top